Nathan Caffo - Net Worth and Insider Trading
Nathan Caffo Net Worth
The estimated net worth of Nathan Caffo is at least $42,900 dollars as of 2024-06-09. Nathan Caffo is the Chief Business Officer of Candel Therapeutics Inc and owns about 6,000 shares of Candel Therapeutics Inc (CADL) stock worth over $42,900. Details can be seen in Nathan Caffo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nathan Caffo has not made any transactions after 2021-07-29 and currently still holds the listed stock(s).
Transaction Summary of Nathan Caffo
Nathan Caffo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathan Caffo owns 2 companies in total, including ALX Oncology Holdings Inc (ALXO) , and Candel Therapeutics Inc (CADL) .
Click here to see the complete history of Nathan Caffo’s form 4 insider trades.
Insider Ownership Summary of Nathan Caffo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 2020-07-16 | Chief Business Officer |
| CADL | Candel Therapeutics Inc | 2021-07-29 | Chief Business Officer |
Nathan Caffo Latest Holdings Summary
Nathan Caffo currently owns a total of 1 stock. Nathan Caffo owns 6,000 shares of Candel Therapeutics Inc (CADL) as of July 29, 2021, with a value of $42,900.
Latest Holdings of Nathan Caffo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2021-07-29 | 6,000 | 7.15 | 42,900 |
Holding Weightings of Nathan Caffo
Nathan Caffo Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathan Caffo has made a total of 1 transactions in Candel Therapeutics Inc (CADL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Candel Therapeutics Inc is the acquisition of 6,000 shares on July 29, 2021, which cost Nathan Caffo around $48,000.
Insider Trading History of Nathan Caffo
- 1
Nathan Caffo Trading Performance
GuruFocus tracks the stock performance after each of Nathan Caffo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nathan Caffo is 53.84%. GuruFocus also compares Nathan Caffo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nathan Caffo within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nathan Caffo's insider trading performs compared to the benchmark.
Performance of Nathan Caffo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.59 | | | | | |
| Relative Return to S&P 500(%) | 7.55 | | | | | |
Nathan Caffo Ownership Network
Nathan Caffo Owned Company Details
What does ALX Oncology Holdings Inc do?
Who are the key executives at ALX Oncology Holdings Inc?
Nathan Caffo is the Chief Business Officer of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include director & President and CEO Jaume Pons , Chief Medical Officer Sophia Randolph , and director & 10 percent owner Jason Lettmann .
ALX Oncology Holdings Inc (ALXO) Insider Trades Summary
Over the past 18 months, Nathan Caffo made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 113,208 shares made by Jaume Pons , a net sale of 10,528 shares made by Shelly Pinto , and a net sale of 13,605 shares made by Sophia Randolph .
In summary, during the past 3 months, insiders sold 122,000 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 4,400 shares, with a net sale of 117,600 shares. During the past 18 months, 138,228 shares of ALX Oncology Holdings Inc (ALXO) were sold and 4,400 shares were bought by its insiders, resulting in a net sale of 133,828 shares.
ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ALX Oncology Holdings Inc Insider Transactions
Nathan Caffo Mailing Address
Above is the net worth, insider trading, and ownership report for Nathan Caffo. You might contact Nathan Caffo via mailing address: C/o Alx Oncology Holdings Inc., 866 Malcolm Road, Suite 100, Burlingame Ca 94010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
